神经纤维瘤病2型(NF2)的治疗策略及听力重建进展(附18例报告)

来源 :中华医学会2015全国神经肿瘤学术大会 | 被引量 : 0次 | 上传用户:lixiaojin1987
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 NF2是一种常染色体显性遗传类疾病,临床少见,一般病程较短,多表现为双侧听神经瘤和/或颅内、椎管内多发性病变.随着病情的进展,患者多进入双耳失聪阶段,严重影响生活质量.本文通过回顾分析我科近十年来收治的NF2患者18例,总结其临床表现、病程发展特点、家族史、治疗方法选择等方面,目的是寻求最佳和最适合NF2患者的治疗策略.
其他文献
Dr.Cicchetti obtained her PhD in neurobiology at Université Laval in Québec (Canada) in 1998.In 2002,she completed a postdoctoral fellowship at Harvard Medical School in the field of cell replacement
会议
Dr.Yus research has focused on the ionic and molecular mechanisms of neuronal cell death and neuroprotection after hypoxia and ischemia in vitro as well as in animal models.
会议
Meng Li graduated from Peking University Health Science Centre (formerly Beijing Medical University),and obtained her PhD under the guidance of Professor Austin Smith at the Institute of Stem Cell Res
会议
Prof.Xiao-Ming Xu received his Medical Diploma from Shanghai Second Medical University and Ph.D.in Anatomy/Neurobiology from The Ohio State University.
会议
Yuan-shan Zeng is a professor of Histology and Embryology.He got his Ph.D.degree of Histology and Embryology in West China University of Medical Sciences in 1991.
会议
Dr.Rongqiao He,a full professor of State Key Laboratory of Brain and Cognitive Science in Institute of Biophysics,Chinese Academy of Sciences,is interested in Neurochemistry,and works on the mechanism
会议
目的 脑胶质瘤手术时判断肿瘤边界对于全切肿瘤非常重要,手术时肉眼下判断肿瘤边界较为困难,目前尚没有理想的方法,示踪染料结合配套的显微镜设备可能对于判断肿瘤边界具有重要价值,因此探索示踪染料结合配套的显微镜设备的使用具有重要意义.回顾2014年2月初至2014年3月中旬我们采用荧光素钠介导,在携带YELLOW560 滤光器的PENTERO 显微镜下切除8例高级别胶质瘤(III-IV 级),在此初步探
会议
胶质母细胞瘤(Glioblastoma,GBM)患者的中位生存期仅为14.6个月.GBM 治疗效果差,因此迫切需要寻找新的更有效的治疗方法.在GBM 中经常出现表皮生长因子受体(Epidermal growth factor receptor,EGFR)扩增和表皮生长因子受体Ⅲ型突变体(Epidermal growth factor receptor variant Ⅲ,EGFRvⅢ),所以EGF
会议
目的 术后残存的胶质瘤细胞往往导致肿瘤复发,并且其复发部位位于肿瘤切除后瘤腔壁2~3厘米的范围内.但是,由于肿瘤的侵袭性术中很难准确判定肿瘤的实际边界.荧光引导手术能在术中准确判定肿瘤的实际边界;同时,光动力学治疗也是一种有效辅助治疗方法.
会议
Objective Giant sellar region tumors(diameter≥ 4.0cm)remain a therapeutic challenge with high mortality and morbidity,we described our surgical experience through diverse transcranial approaches for g
会议